Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Found 403 studies with search of: | "Bortezomib" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Recruiting |
A Phase 1 Dose Escalating Trial of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplasia
|
||||
2 | Recruiting |
Bortezomib (PS-341) in Combination With Carboplatin and Docetaxel for Patients With Advanced Non-Small Cell Lung Cancer
|
||||
3 | Active, not recruiting |
Phase I Study of Weekly Intravenous PS-341 (Bortezomib) Plus Mitoxantrone
|
||||
4 | Recruiting |
Combination High Dose Melphalan and Autologous Peripheral Blood Stem Cell (PBSC) Transplant With Bortezomib for Multiple Myeloma: A Dose and Schedule Finding Study
|
||||
5 | Active, not recruiting |
Study of DOXIL/CAELYX (Pegylated Liposomal Doxorubicin) and VELCADE (Bortezomib) or VELCADE Monotherapy for the Treatment of Relapsed Multiple Myeloma
|
||||
6 | Active, not recruiting |
Bortezomib (Velcade) Plus Rituximab-HyperCVAD in Patients With Mantle Cell Lymphoma
|
||||
7 | Recruiting |
Study of Temsirolimus, Topotecan, and Bortezomib
|
||||
8 | Recruiting |
Randomized Phase 3b Study in Previously Untreated Multiple Myeloma Patients: VELCADE,Thalidomide, and Dexamethasone Versus VELCADE and Dexamethasone Versus VELCADE, Melphalan, and Prednisone
|
||||
9 | Recruiting |
A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma
|
||||
10 | Recruiting |
A Phase I/II Study of Liposomal Doxorubicin (Doxil)/Melphalan/Bortezomib (Velcade) in Relapsed/Refractory Multiple Myeloma
|
||||
11 | Active, not recruiting |
PS-341 Followed by Removal of Prostate for Those With Prostate Cancer
|
||||
12 | Recruiting |
Bortezomib and Reduced Intensity Allogenic Stem Cell Transplantation for Lymphoid Malignancies
|
||||
13 | Recruiting |
Bortezomib and Rituximab for Patients With Waldenstrom's Macroglobulinemia
|
||||
14 | Recruiting |
Ph II Avastin + Bortezomib for Pts w Recurrent Malignant Glioma
|
||||
15 | Recruiting |
Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
|
||||
16 | Not yet recruiting |
Efficacy of Bortezomib (Velcade(R)) in Patients With Advanced Waldenström Macroglobulinemia
|
||||
17 | Active, not recruiting |
Velcade Plus ICE for Patients With Relapsed Classical Hodgkin Lymphoma
|
||||
18 | Active, not recruiting |
Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma
|
||||
19 | Recruiting |
Bevacizumab and Bortezomib in Patients With Advanced Malignancy
|
||||
20 | Recruiting |
Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |